OBJECTIVE: To report on our experience with girls and young women who received treatment for Hodgkin lymphoma, underwent prior oophoropexy to preserve their ovarian function, and subsequently gave birth. DESIGN: Retrospective monoinstitutional evaluation. SETTING: National Cancer Institute. PATIENT(S): Eleven girls given treatment for Hodgkin lymphoma and undergoing bilateral ovarian transposition at a median age of 13 years. INTERVENTION(S): The ovaries were positioned behind the uterus by the general surgeon. MAIN OUTCOME MEASURE(S): Fourteen pregnancies were recorded among these 11 women, with 12 live births (1 twin) and 3 miscarriages. RESULT(S): None of these women needed the ovaries to be relocated, and none of them resorted to artificial insemination. Their median age at the time of first pregnancy was 31 years, and the median time elapsing since ovarian transposition was 14 years. CONCLUSION(S): This series confirms that oophoropexy can preserve ovarian function and enable future pregnancy. We encourage pediatric oncologists, surgeons, and radiotherapists to bear this option in mind when considering female patients for pelvic irradiation.
OBJECTIVE: To report on our experience with girls and young women who received treatment for Hodgkin lymphoma, underwent prior oophoropexy to preserve their ovarian function, and subsequently gave birth. DESIGN: Retrospective monoinstitutional evaluation. SETTING: National Cancer Institute. PATIENT(S): Eleven girls given treatment for Hodgkin lymphoma and undergoing bilateral ovarian transposition at a median age of 13 years. INTERVENTION(S): The ovaries were positioned behind the uterus by the general surgeon. MAIN OUTCOME MEASURE(S): Fourteen pregnancies were recorded among these 11 women, with 12 live births (1 twin) and 3 miscarriages. RESULT(S): None of these women needed the ovaries to be relocated, and none of them resorted to artificial insemination. Their median age at the time of first pregnancy was 31 years, and the median time elapsing since ovarian transposition was 14 years. CONCLUSION(S): This series confirms that oophoropexy can preserve ovarian function and enable future pregnancy. We encourage pediatric oncologists, surgeons, and radiotherapists to bear this option in mind when considering female patients for pelvic irradiation.
Authors: Francesca E Duncan; Jennifer K Jozefik; Alison M Kim; Jennifer Hirshfeld-Cytron; Teresa K Woodruff Journal: US Obstet Gynecol Date: 2011-01-01
Authors: Sana M Salih; Samet Albayrak; Songwon Seo; Sarah L Stewart; Kristen Bradley; David M Kushner Journal: J Reprod Med Date: 2015 Jul-Aug Impact factor: 0.142
Authors: Monika L Metzger; Lillian R Meacham; Briana Patterson; Jacqueline S Casillas; Louis S Constine; Nobuko Hijiya; Lisa B Kenney; Marcia Leonard; Barbara A Lockart; Wendy Likes; Daniel M Green Journal: J Clin Oncol Date: 2013-02-04 Impact factor: 44.544
Authors: Israel Fernandez-Pineda; Andrew M Davidoff; Lu Lu; Bhaskar N Rao; Carmen L Wilson; D Kumar Srivastava; James L Klosky; Monica L Metzger; Matthew J Krasin; Kirsten K Ness; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Charles A Sklar; Daniel M Green; Wassim Chemaitilly Journal: Pediatr Blood Cancer Date: 2018-05-11 Impact factor: 3.167
Authors: Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay Journal: J Clin Oncol Date: 2013-05-28 Impact factor: 44.544